1	NEW	new	JJ	p2=NNP	2	nn	_
2	YORK	york	NNP	p2=NN	56	nn	_
3	,	,	,	_	2	punct	_
4	May	may	NNP	_	56	nn	_
5	19	0	CD	_	4	num	_
6	,	,	,	_	20	punct	_
7	2014	0	CD	_	12	num	_
8	/	/	SYM	p2=,	12	punct	_
9	PRNewswire	prnewswire	NNP	p2=NN	12	nn	_
10	/	/	SYM	_	12	punct	_
11	--	--	:	_	12	punct	_
12	Novocure	novocure	NNP	p2=UH	20	nsubj	20:A0=PAG
13	,	,	,	_	12	punct	_
14	a	a	DT	_	18	det	_
15	commercial	commercial	JJ	_	16	amod	_
16	stage	stage	NN	_	18	nn	_
17	oncology	oncology	NN	p2=IN	18	nn	_
18	company	company	NN	_	12	appos	_
19	,	,	,	_	12	punct	_
20	announced	announce	VBD	pb=announce.01	0	root	_
21	today	today	NN	_	20	npadvmod	20:AM-TMP
22	that	that	IN	_	38	complm	_
23	an	an	DT	_	24	det	_
24	analysis	analysis	NN	_	38	nsubjpass	38:A1=PRD
25	of	of	IN	_	24	prep	_
26	the	the	DT	_	30	det	_
27	efficacy	efficacy	NN	_	30	nn	_
28	and	and	CC	_	27	cc	_
29	safety	safety	NN	_	27	conj	_
30	data	datum	NNS	_	25	pobj	_
31	from	from	IN	_	30	prep	_
32	its	its	PRP$	_	35	poss	_
33	U.S.	u.s.	NNP	_	35	nn	_
34	patient	patient	NN	p2=JJ	35	nn	_
35	registry	registry	NN	_	31	pobj	_
36	will	will	MD	_	38	aux	38:AM-MOD
37	be	be	VB	_	38	auxpass	_
38	published	publish	VBN	pb=publish.01	20	ccomp	20:A1=PPT
39	as	as	IN	_	38	prep	38:AM-PRD
40	part	part	NN	_	39	pobj	_
41	of	of	IN	_	40	prep	_
42	the	the	DT	_	44	det	_
43	50th	#ord#	JJ	_	44	amod	_
44	meeting	meeting	NN	_	41	pobj	_
45	of	of	IN	_	44	prep	_
46	the	the	DT	_	48	det	_
47	American	american	NNP	p2=JJ	48	nn	_
48	Society	society	NNP	_	45	pobj	_
49	of	of	IN	_	48	prep	_
50	Clinical	clinical	JJ	p2=NNP	51	amod	_
51	Oncology	oncology	NNP	p2=NN	49	pobj	_
52	(	(	-LRB-	_	53	punct	_
53	ASCO	asco	NNP	_	51	appos	_
54	)	)	-RRB-	_	53	punct	_
55	in	in	IN	_	51	prep	_
56	Chicago	chicago	NNP	_	55	pobj	_
57	,	,	,	_	51	punct	_
58	IL	il	NN	p2=NNP	40	conj	_
59	from	from	IN	_	58	prep	_
60	May	may	NNP	_	59	pobj	_
61	30	0	CD	p2=NNP	60	num	_
62	-	-	:	p2=SYM	60	punct	_
63	June	june	NNP	_	59	npadvmod	_
64	3	0	CD	_	63	num	_
65	,	,	,	_	63	punct	_
66	2014	0	CD	_	63	num	_
67	.	.	.	_	20	punct	_

1	 	 	:	p2=NFP	6	punct	_
2	The	the	DT	_	5	det	_
3	U.S.	u.s.	NNP	_	5	nn	_
4	patient	patient	NN	p2=JJ	5	nn	_
5	registry	registry	NN	p2=VBD	6	nsubj	6:A2=GOL
6	included	include	VBD	pb=include.01	0	root	_
7	data	datum	NNS	p2=NN	6	dobj	6:A1=PPT
8	for	for	IN	_	7	prep	_
9	all	all	DT	p2=PDT	12	det	_
10	recurrent	recurrent	JJ	p2=NN	12	amod	_
11	glioblastoma	glioblastoma	NN	p2=NNP	12	nn	_
12	patients	patient	NNS	_	8	pobj	13:A1=PPT
13	treated	treat	VBN	p2=VBD|pb=treat.02	12	partmod	_
14	with	with	IN	_	13	prep	13:A2=GOL
15	NovoTTF	novottf	NNP	_	16	nn	_
16	Therapy	therapy	NNP	_	14	pobj	_
17	from	from	IN	_	13	prep	13:AM-TMP
18	October	october	NNP	_	17	pobj	_
19	2011	0	CD	_	18	num	_
20	to	to	IN	_	13	prep	_
21	November	november	NNP	_	20	pobj	_
22	2013	0	CD	_	21	num	_
23	at	at	IN	_	13	prep	13:AM-LOC
24	91	0	CD	_	27	num	_
25	leading	lead	VBG	p2=NN|pb=lead.01	27	amod	_
26	oncology	oncology	NN	p2=IN	27	nn	_
27	centers	center	NNS	_	23	pobj	25:A0=PAG
28	in	in	IN	_	27	prep	_
29	the	the	DT	_	31	det	_
30	United	united	NNP	_	31	nn	_
31	States	states	NNP	_	28	pobj	_
32	(	(	-LRB-	_	31	punct	_
33	n=457	n=457	NNP	p2=RB	31	appos	_
34	)	)	-RRB-	_	31	punct	_
35	.	.	.	_	6	punct	_

1	NovoTTF	novottf	NNP	p2=RB	3	hmod	_
2	-	-	HYPH	_	3	hyph	_
3	100A	100a	NNP	_	4	nn	_
4	System	system	NNP	_	5	nsubj	5:A1=PPT
5	is	be	VBZ	pb=be.01	0	root	_
6	a	a	DT	_	11	det	_
7	portable	portable	JJ	_	11	amod	_
8	,	,	,	_	11	punct	_
9	non-invasive	non-invasive	JJ	_	11	amod	_
10	medical	medical	JJ	_	11	amod	_
11	device	device	NN	_	5	attr	12:A1=PRD;5:A2=PRD
12	designed	design	VBN	pb=design.01	11	partmod	_
13	for	for	IN	_	12	prep	12:A2=GOL
14	continuous	continuous	JJ	_	15	amod	_
15	use	use	NN	_	13	pobj	_
16	by	by	IN	_	12	agent	12:A0=PAG
17	patients	patient	NNS	_	16	pobj	_
18	.	.	.	_	5	punct	_

1	In	in	IN	_	8	prep	8:AM-LOC
2	vitro	vitro	FW	p2=NN	1	pobj	_
3	and	and	CC	_	1	cc	_
4	in	in	IN	_	1	conj	_
5	vivo	vivo	JJ	p2=FW	6	amod	_
6	studies	study	NNS	_	4	pobj	_
7	have	have	VBP	_	8	aux	_
8	shown	show	VBN	pb=show.01	0	root	_
9	that	that	IN	_	15	complm	_
10	the	the	DT	_	14	det	_
11	NovoTTF	novottf	NNP	_	13	hmod	_
12	-	-	HYPH	_	13	hyph	_
13	100A	100a	NNP	_	14	nn	_
14	System	system	NNP	_	15	nsubj	17:A0=PAG;15:A1=PPT
15	slows	slow	VBZ	pb=slow.02	8	ccomp	8:A1=PPT
16	and	and	CC	_	15	cc	_
17	reverses	reverse	VBZ	pb=reverse.01	15	conj	_
18	tumor	tumor	NN	p2=JJ	19	nn	_
19	growth	growth	NN	_	17	dobj	17:A1=PPT
20	by	by	IN	_	17	prep	17:AM-MNR
21	inhibiting	inhibit	VBG	pb=inhibit.01	20	pcomp	_
22	mitosis	mitosis	NN	_	21	dobj	21:A1=PPT
23	,	,	,	_	22	punct	_
24	the	the	DT	_	25	det	_
25	process	process	NN	_	22	appos	29:AM-LOC;31:AM-LOC
26	by	by	IN	_	29	prep	29:R-AM-MNR
27	which	which	WDT	_	26	pobj	_
28	cells	cell	NNS	_	29	nsubj	29:A1=PPT;31:A1=PPT
29	divide	divide	VBP	pb=divide.02	25	rcmod	_
30	and	and	CC	_	29	cc	_
31	replicate	replicate	VBP	pb=replicate.01	29	conj	_
32	.	.	.	_	8	punct	_

1	The	the	DT	_	5	det	_
2	NovoTTF	novottf	NNP	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	100A	100a	NNP	_	5	nn	_
5	System	system	NNP	p2=NN	6	nsubj	6:A0=PAG;15:A0=PAG
6	weighs	weigh	VBZ	pb=weigh.01	0	root	_
7	about	about	RB	p2=IN	8	advmod	_
8	six	#crd#	CD	_	9	num	_
9	pounds	pound	NNS	_	6	dobj	6:A3=VSP
10	(	(	-LRB-	_	9	punct	_
11	three	#crd#	CD	_	12	num	_
12	kilograms	kilogram	NNS	_	9	appos	_
13	)	)	-RRB-	_	9	punct	_
14	and	and	CC	_	6	cc	_
15	creates	create	VBZ	pb=create.01	6	conj	_
16	a	a	DT	_	18	det	_
17	low	low	JJ	_	18	amod	_
18	intensity	intensity	NN	_	15	dobj	15:A1=PPT
19	,	,	,	_	15	punct	_
20	alternating	alternate	VBG	pb=alternate.01	15	advcl	15:AM-ADV
21	electric	electric	JJ	_	22	amod	_
22	field	field	NN	_	20	dobj	20:A1=PPT
23	within	within	IN	_	20	prep	20:A2=PPT
24	a	a	DT	_	25	det	_
25	tumor	tumor	NN	_	23	pobj	27:A0=PAG
26	that	that	WDT	p2=IN	27	nsubj	27:R-A0
27	exerts	exert	VBZ	pb=exert.01	25	rcmod	_
28	physical	physical	JJ	_	29	amod	_
29	forces	force	NNS	_	27	dobj	27:A1=PPT
30	on	on	IN	_	29	prep	_
31	electrically	electrically	RB	_	32	advmod	32:AM-MNR
32	charged	charge	VBN	p2=JJ|pb=charge.05	34	amod	_
33	cellular	cellular	JJ	_	34	amod	_
34	components	component	NNS	_	30	pobj	32:A1=PPT
35	,	,	,	_	27	punct	_
36	preventing	prevent	VBG	pb=prevent.01	27	advcl	_
37	the	the	DT	_	40	det	_
38	normal	normal	JJ	_	40	amod	_
39	mitotic	mitotic	JJ	p2=NN	40	amod	_
40	process	process	NN	_	36	dobj	36:A1=PPT
41	and	and	CC	_	36	cc	_
42	causing	cause	VBG	pb=cause.01	36	conj	_
43	cancer	cancer	NN	_	44	nn	_
44	cell	cell	NN	_	45	nn	_
45	death	death	NN	_	42	dobj	42:A1=PPT
46	.	.	.	_	6	punct	_

1	In	in	IN	_	12	prep	12:AM-LOC
2	patients	patient	NNS	_	1	pobj	_
3	with	with	IN	_	2	prep	_
4	recurrent	recurrent	JJ	p2=NN	7	amod	_
5	glioblastoma	glioblastoma	NN	_	6	nn	_
6	brain	brain	NN	_	7	nn	_
7	tumors	tumor	NNS	_	3	pobj	_
8	,	,	,	_	12	punct	_
9	the	the	DT	_	10	det	_
10	system	system	NN	_	12	nsubj	12:A0=CAU
11	has	have	VBZ	_	12	aux	_
12	shown	show	VBN	pb=show.01	0	root	_
13	clinical	clinical	JJ	_	14	amod	_
14	efficacy	efficacy	NN	p2=JJ	12	dobj	12:A1=PPT
15	comparable	comparable	JJ	_	14	amod	_
16	to	to	IN	_	15	prep	_
17	that	that	DT	_	16	pobj	_
18	of	of	IN	_	17	prep	_
19	active	active	JJ	_	20	amod	_
20	chemotherapies	chemotherapy	NNS	_	18	pobj	_
21	with	with	IN	_	20	prep	_
22	better	good	JJR	_	23	amod	_
23	quality	quality	NN	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	life	life	NN	_	24	pobj	_
26	and	and	CC	_	21	cc	_
27	without	without	IN	_	21	conj	_
28	many	many	JJ	p2=DT	27	pobj	_
29	of	of	IN	_	28	prep	_
30	the	the	DT	_	32	det	_
31	side	side	NN	p2=JJ	32	amod	_
32	effects	effect	NNS	_	29	pobj	_
33	of	of	IN	_	32	prep	_
34	chemotherapy	chemotherapy	NN	_	33	pobj	_
35	.	.	.	_	12	punct	_

1	The	the	DT	_	5	det	_
2	NovoTTF	novottf	NNP	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	100A	100a	NNP	_	5	nn	_
5	System	system	NNP	_	7	nsubj	7:A0=PAG
6	has	have	VBZ	_	7	aux	_
7	received	receive	VBN	pb=receive.01	0	root	_
8	marketing	marketing	NN	p2=VBG	9	nn	_
9	approval	approval	NN	_	7	dobj	7:A1=PPT
10	in	in	IN	_	7	prep	7:AM-LOC
11	the	the	DT	_	13	det	_
12	United	united	NNP	_	13	nn	_
13	States	states	NNP	_	10	pobj	_
14	(	(	-LRB-	_	13	punct	_
15	U.S.	u.s.	NNP	_	13	appos	_
16	)	)	-RRB-	_	13	punct	_
17	and	and	CC	_	7	cc	_
18	is	be	VBZ	_	23	auxpass	_
19	a	a	DT	_	22	det	_
20	CE	ce	NNP	p2=NN	21	nn	_
21	Marked	marked	NNP	p2=VBN	22	nn	_
22	device	device	NN	_	23	nsubjpass	23:A1=PPT
23	cleared	clear	VBN	p2=VBN|pb=clear.02	7	conj	_
24	for	for	IN	_	23	prep	23:AM-PNC
25	sale	sale	NN	_	24	pobj	_
26	in	in	IN	_	25	prep	_
27	the	the	DT	_	29	det	_
28	European	european	NNP	_	29	nn	_
29	Union	union	NNP	_	26	pobj	_
30	,	,	,	_	29	punct	_
31	Switzerland	switzerland	NNP	_	29	conj	_
32	,	,	,	_	31	punct	_
33	Australia	australia	NNP	_	31	conj	_
34	and	and	CC	_	33	cc	_
35	Israel	israel	NNP	_	33	conj	_
36	.	.	.	_	23	punct	_

1	The	the	DT	_	2	det	_
2	FDA	fda	NNP	_	4	nsubj	4:A0
3	has	have	VBZ	_	4	aux	_
4	approved	approve	VBN	pb=approve.01	0	root	_
5	the	the	DT	_	9	det	_
6	NovoTTF	novottf	NNP	_	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	100A	100a	NNP	_	9	nn	_
9	System	system	NNP	_	4	dobj	4:A1=PPT
10	for	for	IN	_	4	prep	_
11	use	use	NN	_	10	pobj	_
12	as	as	IN	_	11	prep	_
13	a	a	DT	_	14	det	_
14	treatment	treatment	NN	_	12	pobj	_
15	for	for	IN	_	14	prep	_
16	adult	adult	NN	_	17	nn	_
17	patients	patient	NNS	_	15	pobj	_
18	(	(	-LRB-	_	17	punct	_
19	22	0	CD	_	20	num	_
20	years	year	NNS	_	17	appos	_
21	of	of	IN	_	20	prep	_
22	age	age	NN	_	21	pobj	_
23	or	or	CC	_	20	cc	_
24	older	old	JJR	_	20	conj	_
25	)	)	-RRB-	_	17	punct	_
26	with	with	IN	_	14	prep	_
27	histologically	histologically	RB	_	29	hmod	_
28	-	-	HYPH	_	29	hyph	_
29	confirmed	confirm	VBN	_	30	amod	_
30	GBM	gbm	NNP	p2=NN	26	pobj	_
31	,	,	,	_	4	punct	_
32	following	follow	VBG	_	4	prep	_
33	histologically	histologically	RB	p2=NN	38	advmod	_
34	-	-	HYPH	p2=:	33	hyph	_
35	or	or	CC	_	33	cc	_
36	radiologically	radiologically	RB	_	38	hmod	_
37	-	-	HYPH	_	38	hyph	_
38	confirmed	confirm	VBN	_	39	amod	_
39	recurrence	recurrence	NN	_	32	pobj	_
40	in	in	IN	_	39	prep	_
41	the	the	DT	_	43	det	_
42	supra-tentorial	supra-tentorial	JJ	_	43	amod	_
43	region	region	NN	_	40	pobj	_
44	of	of	IN	_	43	prep	_
45	the	the	DT	_	46	det	_
46	brain	brain	NN	_	44	pobj	_
47	after	after	IN	_	32	prep	_
48	receiving	receive	VBG	pb=receive.01	47	pcomp	_
49	chemotherapy	chemotherapy	NN	_	48	dobj	48:A1=PPT
50	.	.	.	_	4	punct	_

1	The	the	DT	_	2	det	_
2	system	system	NN	_	4	nsubjpass	7:A1=PPT;4:A2=VSP;13:A2=VSP
3	is	be	VBZ	_	4	auxpass	_
4	intended	intend	VBN	pb=intend.01	0	root	_
5	to	to	TO	_	7	aux	_
6	be	be	VB	_	7	auxpass	_
7	used	use	VBN	pb=use.01	4	xcomp	4:A1=PPT
8	as	as	IN	_	7	prep	7:A2=PRP
9	monotherapy	monotherapy	NN	_	8	pobj	_
10	,	,	,	_	4	punct	_
11	and	and	CC	_	4	cc	_
12	is	be	VBZ	_	13	auxpass	_
13	intended	intend	VBN	pb=intend.01	4	conj	_
14	as	as	IN	_	13	prep	13:A1=PPT
15	an	an	DT	_	16	det	_
16	alternative	alternative	NN	_	14	pobj	_
17	to	to	IN	_	16	prep	_
18	standard	standard	JJ	_	20	amod	_
19	medical	medical	JJ	_	20	amod	_
20	therapy	therapy	NN	_	17	pobj	_
21	for	for	IN	_	16	prep	_
22	GBM	gbm	NNP	p2=NN	21	pobj	_
23	after	after	IN	_	30	mark	_
24	surgical	surgical	JJ	_	27	amod	_
25	and	and	CC	_	24	cc	_
26	radiation	radiation	NN	_	24	conj	_
27	options	option	NNS	_	30	nsubjpass	30:A1=PPT
28	have	have	VBP	_	30	aux	_
29	been	be	VBN	_	30	auxpass	_
30	exhausted	exhaust	VBN	p2=JJ|pb=exhaust.01	16	advcl	_
31	.	.	.	_	4	punct	_

1	Patients	patient	NNS	_	4	nsubj	4:A0=PAG
2	should	should	MD	_	4	aux	4:AM-MOD
3	only	only	RB	_	4	advmod	4:AM-ADV
4	use	use	VB	pb=use.01	0	root	_
5	the	the	DT	_	9	det	_
6	NovoTTF	novottf	NNP	_	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	100A	100a	NNP	_	9	nn	_
9	System	system	NNP	_	4	dobj	4:A1=PPT
10	under	under	IN	_	4	prep	4:A2=PRP
11	the	the	DT	_	12	det	_
12	supervision	supervision	NN	_	10	pobj	_
13	of	of	IN	_	12	prep	_
14	a	a	DT	_	15	det	_
15	physician	physician	NN	_	13	pobj	17:A1=PRD
16	properly	properly	RB	_	17	advmod	17:AM-MNR
17	trained	train	VBN	pb=train.01	15	partmod	_
18	in	in	IN	_	17	prep	17:A2=PPT
19	use	use	NN	_	18	pobj	_
20	of	of	IN	_	19	prep	_
21	the	the	DT	_	22	det	_
22	system	system	NN	_	20	pobj	_
23	.	.	.	_	4	punct	_

1	Full	full	JJ	_	3	amod	_
2	prescribing	prescribing	JJ	p2=VBG	3	amod	_
3	information	information	NN	_	4	nsubj	4:A1=PPT
4	is	be	VBZ	pb=be.01	0	root	_
5	available	available	JJ	_	4	acomp	4:A2=PRD
6	at	at	IN	_	4	prep	_
7	www.novottftherapy.com	#url#	ADD	_	6	pobj	_
8	 	 	,	p2=VBN	6	punct	_
9	or	or	CC	_	6	cc	_
10	by	by	IN	_	6	conj	_
11	calling	call	VBG	pb=call.01	10	pcomp	_
12	toll	toll	NN	_	13	npadvmod	_
13	free	free	JJ	_	14	amod	_
14	1-855-281-9301	0	CD	p2=LS	11	dobj	11:A1=PPT
15	.	.	.	_	4	punct	_

1	Novocure	novocure	NNP	p2=UH	2	nn	_
2	Limited	limited	NNP	_	3	nsubj	3:A1=PPT
3	is	be	VBZ	pb=be.01	0	root	_
4	a	a	DT	_	9	det	_
5	private	private	JJ	_	9	amod	_
6	Jersey	jersey	NNP	_	7	nn	_
7	Isle	isle	NNP	_	9	nn	_
8	oncology	oncology	NN	p2=IN	9	nn	_
9	company	company	NN	_	3	attr	10:A0=PAG;3:A2=PRD
10	pioneering	pioneer	VBG	pb=pioneer.01	9	partmod	_
11	a	a	DT	_	13	det	_
12	novel	novel	JJ	p2=NN	13	amod	_
13	therapy	therapy	NN	_	10	dobj	10:A1=GOL
14	for	for	IN	_	13	prep	_
15	solid	solid	JJ	_	16	amod	_
16	tumors	tumor	NNS	_	14	pobj	17:A1=PPT
17	called	call	VBN	p2=VBD|pb=call.01	16	partmod	_
18	NovoTTF	novottf	NNP	_	19	nn	_
19	Therapy	therapy	NNP	_	17	oprd	17:A2=PRD
20	.	.	.	_	3	punct	_

1	Novocure	novocure	JJ	p2=NNP	3	amod	_
2	U.S.	u.s.	NNP	_	3	nn	_
3	operations	operation	NNS	_	5	nsubjpass	5:A1=PPT
4	are	be	VBP	_	5	auxpass	_
5	based	base	VBN	pb=base.01	0	root	_
6	in	in	IN	_	5	prep	5:AM-LOC
7	Portsmouth	portsmouth	NNP	_	6	pobj	_
8	,	,	,	_	7	punct	_
9	NH	nh	NNP	_	7	conj	_
10	and	and	CC	_	9	cc	_
11	New	new	NNP	_	12	nn	_
12	York	york	NNP	_	9	conj	_
13	,	,	,	_	9	punct	_
14	NY	ny	NNP	p2=UH	9	appos	_
15	.	.	.	_	5	punct	_

1	Additionally	additionally	RB	_	5	advmod	5:AM-DIS
2	,	,	,	_	5	punct	_
3	the	the	DT	_	4	det	_
4	company	company	NN	_	5	nsubj	5:A0=PAG
5	has	have	VBZ	pb=have.03	0	root	_
6	offices	office	NNS	_	5	dobj	5:A1=PPT
7	in	in	IN	_	6	prep	_
8	Switzerland	switzerland	NNP	_	7	pobj	_
9	and	and	CC	_	8	cc	_
10	Japan	japan	NNP	_	8	conj	_
11	and	and	CC	_	6	cc	_
12	a	a	DT	_	14	det	_
13	research	research	NN	_	14	nn	_
14	center	center	NN	_	6	conj	_
15	in	in	IN	_	14	prep	_
16	Haifa	haifa	NNP	_	15	pobj	_
17	,	,	,	_	16	punct	_
18	Israel	israel	NNP	_	16	appos	_
19	.	.	.	_	5	punct	_

1	For	for	IN	p2=CC	9	prep	9:AM-PRP
2	additional	additional	JJ	_	3	amod	_
3	information	information	NN	_	1	pobj	_
4	about	about	IN	_	3	prep	_
5	the	the	DT	_	6	det	_
6	company	company	NN	_	4	pobj	_
7	,	,	,	_	9	punct	_
8	please	please	UH	p2=VB	9	intj	9:AM-DIS
9	visit	visit	VB	pb=visit.01	0	root	_
10	www.novocure.com	#url#	ADD	_	9	dobj	9:A1=COM
11	.	.	.	_	9	punct	_

